Abstract:TREM2 depletion exacerbates WMI and cognitive deficits after TBI. TREM2 upregulation alleviates WMI and promotes cognition recovery after TBI. DHCR24 is upregulated after TBI in TREM2 KO mice and can be inhibited by TREM2 upregulation. TREM2 may alleviate WMI after TBI by regulating DHCR24/LXR pathway in microglia. Background White matter injury (WMI) is an important pathological process after traumatic brain injury (TBI). The correlation between white matter functions and the myeloid cells expressing triggering receptor‐2 (TREM2) has been convincingly demonstrated. Moreover, a recent study revealed that microglial sterol metabolism is crucial for early remyelination after demyelinating diseases. However, the potential roles of TREM2 expression and microglial sterol metabolism in WMI after TBI have not yet been explored. Methods Controlled cortical injury was induced in both wild‐type (WT) and TREM2 depletion (TREM2 KO) mice to simulate clinical TBI. COG1410 was used to upregulate TREM2, while PLX5622 and GSK2033 were used to deplete microglia and inhibit the liver X receptor (LXR), respectively. Immunofluorescence, Luxol fast blue staining, magnetic resonance imaging, transmission electron microscopy, and oil red O staining were employed to assess WMI after TBI. Neurological behaviour tests and electrophysiological recordings were utilized to evaluate cognitive functions following TBI. Microglial cell sorting and transcriptomic sequencing were utilized to identify alterations in microglial sterol metabolism‐related genes, while western blot was conducted to validate the findings. Results TREM2 expressed highest at 3 days post‐TBI and was predominantly localized to microglial cells within the white matter. Depletion of TREM2 worsened aberrant neurological behaviours, and this phenomenon was mediated by the exacerbation of WMI, reduced renewal of oligodendrocytes, and impaired phagocytosis ability of microglia after TBI. Subsequently, the upregulation of TREM2 alleviated WMI, promoted oligodendrocyte regeneration, and ultimately facilitated the recovery of neurological behaviours after TBI. Finally, the expression of DHCR24 increased in TREM2 KO mice after TBI. Interestingly, TREM2 inhibited DHCR24 and upregulated members of the LXR pathway. Moreover, LXR inhibition could partially reverse the effects of TREM2 upregulation on electrophysiological activities. Conclusions We demonstrate that TREM2 has the potential to alleviate WMI following TBI, possibly through the DHCR24/LXR pathway in microglia.

The versatile role of TREM2 in regulating of microglia fate in the ischemic stroke

TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury

TREM2 Protects Against Cerebral Ischemia/reperfusion Injury

TREM2 Activation Attenuates Neuroinflammation and Neuronal Apoptosis Via PI3K/Akt Pathway after Intracerebral Hemorrhage in Mice.

TREM2 Impairs Glycolysis to Interrupt Microglial M1 Polarization and Inflammation via JAK2/STAT3 Axis

TREM2‐IGF1 Mediated Glucometabolic Enhancement Underlies Microglial Neuroprotective Properties During Ischemic Stroke

Astrocyte-TREM2 alleviates brain injury by regulating reactive astrocyte states following ischemic stroke

Microglial TREM-1 Receptor Mediates Neuroinflammatory Injury Via Interaction with SYK in Experimental Ischemic Stroke.

TREM2 alleviates white matter injury after traumatic brain injury in mice might be mediated by regulation of DHCR24/LXR pathway in microglia

Distinct myeloid population phenotypes dependent on TREM2 expression levels shape the pathology of traumatic versus demyelinating CNS disorders

TREM2 Regulates Innate Immunity in Alzheimer’s Disease

Role of TREM2 in the Development of Neurodegenerative Diseases after Traumatic Brain Injury

Soluble TREM2 Induces Inflammatory Responses and Enhances Microglial Survival

Elevating Microglia TREM2 Reduces Amyloid Seeding and Suppresses Disease-Associated Microglia

TMEM59 Interacts with TREM2 and Modulates TREM2-dependent Microglial Activities

TREM2 in Alzheimer's Disease: Microglial Survival and Energy Metabolism.

Novel insights into the role of TREM2 in cerebrovascular diseases

O4‐02‐01: SOLUBLE TREM2 MODULATES MICROGLIAL FUNCTION AND PROTECTS AGAINST AMYLOID PATHOLOGY

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model

TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target

Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity